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Abstract - Several new synthetic methods for B-10 containing nucleoside 
derivatives have been developed. (1) The palladium-catalyzed coupling reaction 
of halogenated nucleoside derivatives with the aryltin compound having a boronic 
moiety proceeds chemoselectively at the C-Sn bond rather than the C-B bond to 
give boron-containing nucleoside derivatives. (2) The 1,2-addition reaction of 
the carbanions, generated from nucleoside derivatives, with aromatic aldehydes 
having boronic moiety gives boronated nucleoside derivatives bearing a hydroxy 
group. ( 3 )  The reaction of nucleoside derivatives having an acetylene group 
with decaborane produces carborane containing nucleosides. ( 4 )  Boron containing 
amino acid derivatives, which have both hydrophilic and liphophilic moiety, have 
been prepared. The cytotoxicity of the boron-containing biorelated compounds, 
and their application to neutron capture therapy are discussed. 
INTRODUCTION 
The theoretical attractiveness of neutron capture therapy (NCT) versus other radio- and 
chemotherapic approaches for the treatment of cancer is as appealing now as when first proposed by 
Locher (ref. 1). The interaction of boron-10 and thermal neutron produces intense, ionizing 
radiation that is confined to single or adjacent cancer cells. 
Since a practical method for production of highly purified thermal neutron has been accomplished, 
much attention has been paid to the design and synthesis of boron-10 (l0B) carriers that deliver 
adequate concentration of l0B atoms to t w r s  (ref. 2). 
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PREPARATION OF MONO-BORON CONTAINING CARRIERS 
We have developed several new synthetic methods for B-10 containing bio-related molecules. (1) The 
palladium-catalyzed coupling reaction of halogenated nucleoside derivatives with the aryltin 
compound having a boronic moiety proceeded chemoselectively at the C-Sn bond rather than the C-B 
bond to give boron containing nucleoside derivatives in good yields (eq. 1) (ref. 3 ) .  The use of 
Pd(PPh))4 as a catalyst, and use of a less polar solvent such as 
Pd cat 
R - X  t Bu3Sn-Ar-B(OR1)2 - R-Ar-B(OR1)2 eq 1 
toluene and of higher reaction temperature were essential to achieve the coupling. The use of 
acetonide and methoxymethyl group as the sugar protecting group, or the reaction without protection 
gave poor results. The sterically bulky t-butyldimethylsilyl group afforded the coupling products 
in much higher yields. The compounds prepared by the Pd-catalyzed coupling are shown in Scheme 1. 
Scheme 1 B-10 Carriers Prepared by Pd-catalyzed Coupling Reactions 
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One of the most often used procedures for preparation of l0B carriers is the direct reaction of the 
carbanions YLi with trialkyl borates (substitution reaction) (ref. 4 ) .  However, the desired 
coupling does not take place in certain cases. ( 2 )  We anticipated that the 1,2-addition of YLi to 
aldehyde group would proceed more readily and rapidly than the substitution reaction; YH=nucleoside 
derivatives. Actually, YLi reacted selectively with the aldehyde group in the presence of boronic 
groups, giving the boron containing biologically active compounds (eq. 2 )  (ref. 5). Here also, 
proper choice of the protective group of boronic acid was important for obtaining the coupling 
product in high yield. Use of N-methyldiethanolamine gave the best result. The compounds prepared 
by this method are sham in Scheme 2 .  
Scheme 2 B- 10 Carriers Prepared by Condensations via Aldehydes Having Boronic Moiety 
TOXICITY OF SOME CARRIERS 
Toxicity of the above I0B carriers toward HeLa-S3 cells was investigated by Prof. Ujeno's group at 
Kyoto University (ref. 6). Some of the results are shown in Scheme 3. As the drug concentration 
increased from 0 to 0.7xlO-*M in H20, the surviving fractions of U1 and U2 were always greater than 
1.0. Accordingly, it is clear that the boronic acid derivatives (U1 and U2) are not toxic toward 
HeLa-S3 cells at the concentration of 0.7~10-~M. Much concentrated solution could not be prepared 
because of low solubility of U1 and U2 in H2O. However, the compounds having the sugar moiety, as 
shown in other examples, were very soluble in water. These compounds exhibided no toxicity toward 
HeLa-S3 cells even in much higher concentrations. 
Scheme 3 
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PREPARATION OF POLY-BORON CONTAINING CARRIERS 
( 3 )  We next examined the preparation of decaborane containing uridine and guanosine derivatives 
(ref. 7 ) .  It is known that the reaction of acetylenic derivatives with decaborane produces 1.2- 
dicarba-closo-dodecaborane (12) (ref. 8). Our strategy is shown in eq 3 .  The acetylene derivatives 
of nucleosides, derived from the palladium catalyzed coupling between acetylene and RX(R: 
nucleoside), were treated with B10H14 in the presence of CH$N, giving the desired products in good 
yields. An application of the 
carbanion condensation method mentioned in eq 2 to the aldehyde having an ortho-carborane moiety 
was also examined (ref, 9). The reaction of YLi with the R-substituted aldehyde proceeded 
smoothly, giving the desired product (eq 4 ) .  If R was hydrogen, that is, if the un-substituted 
aldehyde was used, the condensation did not take place. Presumably, the hydrogen abstraction by 
YLi took place, giving polymerized materials. The compounds prepared by this procedure are also 
shown in Scheme 4 .  
The compounds prepared by this method are shown in Scheme 4 .  
Scheme 4 B-10 Carriers Containing Carborane Structure 
HYDROPHlLlClTY AND LlPOPHlLlClTY INVESTIGATION OF CARRIERS 
Hydrophilic character is required for B-10 carriers in order to be delivered to cancer cells. On 
the other hand, lipophilic character is needed to penetrate cell membrane. According, an 
amphiphilic characteristic is essential for an ideal carrier. We intended to prepare such 
conpounds, and a typical example is shown in Scheme 5 (ref. 10). The chain length of hydrocarbon 
part, and a liphophilic part, can be changed at will. The length of alcohol (after debenzylation) 
chain (a hydrophilic part) also can be changed. The two chains were combined via the amide bonds. 
The carrier is connected to the carborane moiety again via the amide bond. 
An Arnphiphilic Carrier 
r C o N H W  b 
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Scheme5 Preparation of B-10 Carriers Having an Amphiphilic Character 
OBnl 
The partition coefficient of the carriers (m=l and n=4. or m=l and n=8) was investigated. The 
result is shown in Scheme 6. When the length of lipophilic part increased, needless to say, the 
solubility to the organic solvents increased. The compound with m=l and n=8 was soluble both in 
water and in organic solvents. So, we are now in a position to have an amphiphilic carrier. 
Scheme 6 Control of Hydrophilicitynipophilicity 
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